Actemra

Actemra is an FDA-approved brand-name prescription drug used to treat rheumatoid arthritis, certain types of  juvenile idiopathic arthritis, giant cell arteritis (inflammation of the arteries), and cytokine release syndrome. In all these conditions, the body's immune system mistakenly attacks cells in the joints or blood vessels, causing swelling, stiffness, and pain. The active ingredient in Actemra, tocilizumab, suppresses the immune system and “slows down” the body's attack on the joints and blood vessels. Actemra is classified as an interleukin-6 (IL-6) receptor antagonist. Actemra is usually administered by a healthcare professional, but a self-injecting Actemra pen is available by prescription.

This is a limited availability drug and is not available at most pharmacies

We recommend contacting your insurance company about the availability of this drug.

About Actemra

Actemra is an FDA-approved brand-name prescription drug used to treat rheumatoid arthritis, certain types of  juvenile idiopathic arthritis, giant cell arteritis (inflammation of the arteries), and cytokine release syndrome. In all these conditions, the body's immune system mistakenly attacks cells in the joints or blood vessels, causing swelling, stiffness, and pain. The active ingredient in Actemra, tocilizumab, suppresses the immune system and “slows down” the body's attack on the joints and blood vessels. Actemra is classified as an interleukin-6 (IL-6) receptor antagonist. Actemra is usually administered by a healthcare professional, but a self-injecting Actemra pen is available by prescription.

About Actemra

Actemra is an FDA-approved brand-name prescription drug used to treat rheumatoid arthritis, certain types of  juvenile idiopathic arthritis, giant cell arteritis (inflammation of the arteries), and cytokine release syndrome. In all these conditions, the body's immune system mistakenly attacks cells in the joints or blood vessels, causing swelling, stiffness, and pain. The active ingredient in Actemra, tocilizumab, suppresses the immune system and “slows down” the body's attack on the joints and blood vessels. Actemra is classified as an interleukin-6 (IL-6) receptor antagonist. Actemra is usually administered by a healthcare professional, but a self-injecting Actemra pen is available by prescription.

Subscribe to our savings newsletter

Health education, drug info, wellness & more

By clicking 'Subscribe', I agree to SingleCare's Terms & Conditions.